GlaxoSmithKline logo

Quarterly results

We announce our results on a quarterly basis.

This section contains details of our results announcements, to view and download, along with links to related webcasts and presentations.

Results from previous years are archived by date, and can be accessed from the tabs below.


Fourth Quarter 2009

4 February 2010

Andrew Witty

GSK delivers 2009 EPS of 121.2p before major restructuring* and dividend of 61p (+4p)

  • Strategy supports return to sales growth (+3%)
  • Sustained R&D productivity; with further actions to improve returns






Third quarter 2009

28 October 2009

Andrew Witty

GSK delivers Q3 EPS of 28.5p before major restructuring* and dividend of 15p up 7%

  • Return to sales growth with Q3 turnover +3% CER; +15% sterling
  • Continued improvement expected in Q4




Second Quarter 2009

22 July 2009

Andrew Witty

GSK delivers Q2 EPS of 31p before major restructuring* and dividend of 14p up 8%

  • Improving performance to continue in second half of 2009
  • Good progress made to deliver strategic priorities




First Quarter 2009

22 April 2009

Andrew Witty

GSK delivers Q1 EPS of 26.3p before major restructuring* and increased dividend of 14p

 

 





Share price

LSE
1,406p
-13.50

07 Feb 2012 04:35 pm BST
NYSE
44.80
-0.29

07 Feb 2012 04:00 pm EDT
London Stock Exchange price updated every 15 minutes. Provided by Investis Limited.


PDF files

To view PDF documents you may need to install Adobe Reader. PDF links on this site open in a new tab.